Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma.
Takashi NakagawaToshiki KijimaNaoki ImasatoAkihiko NagoshiGaku NakamuraToshitaka UematsuIssei SuzukiDaisaku NishiharaTakao KamaiPublished in: IJU case reports (2022)
Cabozantinib, alone or in combination with immune checkpoint inhibitors, may be a viable option for clear cell renal cell carcinoma with brain metastases.